T
ALXN

TradeWorx’s Alexion Pharmaceuticals ALXN Stock Holding History

TradeWorx’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,143
Closed -$804K – 400
2014
Q2 		$804K Buy
5,143
+1,164
+29% +$184K 0.65% 17
2014
Q1 		$605K Buy
+3,979
New +$633K 0.53% 31

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TradeWorx's ALXN Position: Q3 2014 in Review

TradeWorx sold out of Alexion Pharmaceuticals (ALXN) in Q3 2014, closing a stake of 5,143 shares — an estimated $804K sold.

TradeWorx first reported a position in ALXN in Q1 2014 and held it in 2 quarters. The position peaked at $804K in Q2 2014. 522 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

  • TradeWorx reported no remaining Alexion Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • TradeWorx sold 5,143 Alexion Pharmaceuticals shares in Q3 2014, an estimated $804K.
  • TradeWorx first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • TradeWorx's Alexion Pharmaceuticals position peaked at $804K in Q2 2014.
  • 522 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on TradeWorx's 13F filing for Q3 2014, filed 1 Oct 2014.